Published in Inflamm Res on May 08, 2010
Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study. Intensive Care Med (2014) 2.14
Fasciola hepatica Kunitz type molecule decreases dendritic cell activation and their ability to induce inflammatory responses. PLoS One (2014) 0.83
Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation. BMC Complement Altern Med (2013) 0.79
New Kunitz-Type HCRG Polypeptides from the Sea Anemone Heteractis crispa. Mar Drugs (2015) 0.77
Continuous infusion of high-dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study. Thorac Cancer (2016) 0.75
Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS One (2017) 0.75
Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol (2007) 3.62
TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans (2006) 2.20
Trypsin-pancreatic trypsin inhibitor association. Dynamics of the interaction and role of disulfide bridges. Biochemistry (1972) 1.76
Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. J Biol Chem (2004) 1.73
Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis. Crit Care Med (2002) 1.60
TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. J Immunol (1993) 1.53
Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan. J Biol Chem (2005) 1.51
Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene (2006) 1.47
Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem (1997) 1.45
The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner. J Biol Chem (2002) 1.39
The inter-alpha-inhibitor family: from structure to regulation. Biochem J (1996) 1.35
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer (2008) 1.34
Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem (2003) 1.29
Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res (2005) 1.27
Bikunin--not just a plasma proteinase inhibitor. Int J Biochem Cell Biol (2000) 1.27
The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol (2007) 1.24
Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol (2006) 1.22
TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release. Am J Respir Cell Mol Biol (2006) 1.21
PTX3 interacts with inter-alpha-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion. J Biol Chem (2007) 1.20
Pattern recognition by pentraxins. Adv Exp Med Biol (2009) 1.19
Regulation of the epithelial Na+ channel by peptidases. Curr Top Dev Biol (2007) 1.17
Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock (2001) 1.14
The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. Curr Protein Pept Sci (2003) 1.13
Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells. J Am Soc Nephrol (2006) 1.11
Structure, function and biology of tissue factor pathway inhibitor-2. Thromb Haemost (2005) 1.10
Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci (2003) 1.10
Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease. Drug News Perspect (2008) 1.08
Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6. Arthritis Res Ther (2003) 1.08
Proteins of the inter-alpha-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid. J Biol Chem (1994) 1.07
The protease inhibitor bikunin, a novel anti-metastatic agent. Biol Chem (2003) 1.05
Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol (2002) 1.05
Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane. J Biol Chem (2009) 1.04
Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition. J Biol Chem (2005) 1.02
Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp Biol Med (Maywood) (2005) 1.01
Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem (2002) 1.01
The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice. Am J Pathol (2009) 1.01
Delayed administration of human inter-alpha inhibitor proteins reduces mortality in sepsis. Crit Care Med (2004) 1.00
ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2. J Biol Chem (2006) 1.00
Bikunin (urinary trypsin inhibitor): structure, biological relevance, and measurement. Adv Clin Chem (2007) 1.00
Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Mol Biol (2007) 0.99
Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int J Cancer (2006) 0.99
Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDa protein. J Biol Chem (1990) 0.98
Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis (2000) 0.97
Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation. Hepatobiliary Pancreat Dis Int (2009) 0.96
Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo. Thromb Haemost (2005) 0.96
Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor heavy chains which are attached to a chondroitin sulfate proteoglycan other than bikunin. Osteoarthritis Cartilage (2008) 0.93
Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography. Hoppe Seylers Z Physiol Chem (1981) 0.92
Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury. Ann N Y Acad Sci (2007) 0.91
Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression. Am J Physiol Heart Circ Physiol (2004) 0.90
Bikunin suppresses lipopolysaccharide-induced lethality through down-regulation of tumor necrosis factor- alpha and interleukin-1 beta in macrophages. J Infect Dis (2005) 0.90
Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler Thromb Vasc Biol (2006) 0.89
Aprotinin and the protease-activated receptor 1 thrombin receptor: antithrombosis, inflammation, and stroke reduction. Semin Cardiothorac Vasc Anesth (2006) 0.87
Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. Arch Biochem Biophys (1999) 0.87
Molecular heterogeneity of placental protein 5 (PP5) in late pregnancy serum and plasma: evidence for a heparin-PP5 polymer. Clin Chim Acta (1980) 0.86
In vivo binding of human inter-alpha-trypsin inhibitor free heavy chains to hyaluronic acid. Biol Chem Hoppe Seyler (1994) 0.86
Inter-alpha-trypsin inhibitor promotes bronchial epithelial repair after injury through vitronectin binding. J Biol Chem (2009) 0.86
Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost (2003) 0.86
Enhanced spontaneous metastasis in bikunin-deficient mice. Int J Cancer (2006) 0.85
Bikunin target genes in ovarian cancer cells identified by microarray analysis. J Biol Chem (2003) 0.84
Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion. J Surg Res (2000) 0.84
Regulation and regulatory role of proteinase inhibitors. Crit Rev Eukaryot Gene Expr (1995) 0.84
Benefits and risks of aprotinin use during cardiac surgery. Pharmacotherapy (2008) 0.82
Complement and autoimmunity. Biomed Pharmacother (2003) 0.82
Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells. Anticancer Res (2008) 0.82
Expression of inter-alpha-trypsin inhibitor light chain (bikunin) in human pancreas. J Biochem (1996) 0.81
Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model. Saudi Med J (2008) 0.81
Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters. Biochim Biophys Acta (2001) 0.80
Recombinant tissue factor pathway inhibitor induces apoptosis in cultured rat mesangial cells via its Kunitz-3 domain and C-terminal through inhibiting PI3-kinase/Akt pathway. Apoptosis (2007) 0.80
Aprotinin and renal dysfunction. Expert Opin Drug Saf (2008) 0.79
Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries. Gynecol Obstet Invest (1996) 0.79
Inflammation--a lifelong companion. Attempt at a non-analytical holistic view. Folia Microbiol (Praha) (2007) 0.79
Cathepsin B and its interacting proteins, bikunin and TSRC1, correlate with TNF-induced apoptosis of ovarian cancer cells OV-90. FEBS Lett (2005) 0.78
Distribution and localization of inter-alpha-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohistochemical study. Inflammation (1991) 0.78
Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation. World J Gastroenterol (2005) 0.77
Bikunin suppresses expression of pro-inflammatory cytokines induced by lipopolysaccharide in neutrophils. J Endotoxin Res (2007) 0.77
Urinary trypsin inhibitor suppresses the production of interstitial procollagenase/proMMP-1 and prostromelysin 1/proMMP-3 in human uterine cervical fibroblasts and chorionic cells. FEBS Lett (1997) 0.77
URINARY TRYPSIN INHIBITOR (MINGIN): TRANSFORMATION INTO A NEW TRYPSIN INHIBITOR BY ACID HYDROLYSIS OR BY SIALIDASE. Nature (1964) 0.77
Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells. Hum Cell (2009) 0.76
Hyaluronan, platelets, and monocytes: a novel pro-inflammatory triad. Am J Pathol (2009) 0.76
Urinary trypsin inhibitor suppresses vascular smooth muscle contraction by inhibition of Ca2+ influx. Biochim Biophys Acta (1998) 0.76
Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor. Biochim Biophys Acta (2000) 0.76
Proinflammatory cytokines up-regulate synthesis and secretion of urinary trypsin inhibitor in human hepatoma HepG2 cells. Hepatol Res (2004) 0.76
Efficacy and safety of aprotinin in cardiac surgery. Orthopedics (2004) 0.75
Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev (2003) 3.95
A simplified laminin nomenclature. Matrix Biol (2005) 3.81
Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts. J Cell Biol (2004) 3.00
Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell (2013) 2.58
Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem (2005) 2.04
Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLoS Biol (2007) 1.82
Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol (2008) 1.61
Modulation of CREB activity by the Rho GTPase regulates cell and organism size during mouse embryonic development. Dev Cell (2002) 1.58
A mouse model expressing a truncated form of ameloblastin exhibits dental and junctional epithelium defects. Matrix Biol (2009) 1.50
Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma. Mod Pathol (2011) 1.38
Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1. Dev Biol (2007) 1.37
Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J Exp Med (2011) 1.36
Retracted A Krüppel-associated box-zinc finger protein, NT2, represses cell-type-specific promoter activity of the alpha 2(XI) collagen gene. Mol Cell Biol (2002) 1.32
Staphylococcus aureus MazF specifically cleaves a pentad sequence, UACAU, which is unusually abundant in the mRNA for pathogenic adhesive factor SraP. J Bacteriol (2009) 1.31
Pannexin 3 functions as an ER Ca(2+) channel, hemichannel, and gap junction to promote osteoblast differentiation. J Cell Biol (2011) 1.29
TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. J Biol Chem (2007) 1.27
High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy. Ophthalmology (2010) 1.23
Essential roles of ameloblastin in maintaining ameloblast differentiation and enamel formation. Cells Tissues Organs (2005) 1.19
Pannexin 3 regulates intracellular ATP/cAMP levels and promotes chondrocyte differentiation. J Biol Chem (2010) 1.18
All four putative selectivity filter glycine residues in KtrB are essential for high affinity and selective K+ uptake by the KtrAB system from Vibrio alginolyticus. J Biol Chem (2005) 1.18
Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One (2009) 1.17
Laminin alpha5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. J Biol Chem (2005) 1.17
Potassium/proton antiport system of Escherichia coli. J Biol Chem (2006) 1.17
Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review). Oncol Rep (2010) 1.16
Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development. Proc Natl Acad Sci U S A (2013) 1.16
Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. Nat Neurosci (2002) 1.14
Na+-dependent K+ uptake Ktr system from the cyanobacterium Synechocystis sp. PCC 6803 and its role in the early phases of cell adaptation to hyperosmotic shock. J Biol Chem (2004) 1.11
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity. J Clin Invest (2014) 1.11
Noncognate Mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact. J Biol Chem (2010) 1.11
Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J Biol Chem (2004) 1.10
Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev Biol (2009) 1.09
Identification and characterization of versican/PG-M aggregates in cartilage. J Biol Chem (2006) 1.09
Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care (2005) 1.08
Critical role of heparin binding domains of ameloblastin for dental epithelium cell adhesion and ameloblastoma proliferation. J Biol Chem (2009) 1.08
Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem (2003) 1.07
Laminin alpha1 chain LG4 module promotes cell attachment through syndecans and cell spreading through integrin alpha2beta1. J Biol Chem (2006) 1.05
A case of intravenous leiomyomatosis with high levels of hyaluronan. J Obstet Gynaecol Res (2010) 1.04
Transcription factor epiprofin is essential for tooth morphogenesis by regulating epithelial cell fate and tooth number. J Biol Chem (2007) 1.04
Ovarian endometrioma--risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol (2007) 1.04
Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review. Int J Gynecol Cancer (2009) 1.04
Chondrodysplasia of gene knockout mice for aggrecan and link protein. Glycoconj J (2003) 1.03
Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. J Cell Sci (2009) 1.03
The Krüppel-like factor epiprofin is expressed by epithelium of developing teeth, hair follicles, and limb buds and promotes cell proliferation. J Biol Chem (2003) 1.03
Enhanced immunoresponse of antibody/mixed-PEG co-immobilized surface construction of high-performance immunomagnetic ELISA system. J Colloid Interface Sci (2007) 1.02
Role of epithelial-stem cell interactions during dental cell differentiation. J Biol Chem (2012) 1.02
Cut-off value of D-dimer for prediction of deep venous thrombosis before treatment in ovarian cancer. J Gynecol Oncol (2012) 1.02
Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab (2009) 1.02
Structural and functional studies of the HAMP domain of EnvZ, an osmosensing transmembrane histidine kinase in Escherichia coli. J Biol Chem (2007) 1.02
Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet (2002) 1.02
Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review). Oncol Rep (2009) 1.01
Review: extracellular matrix regulates tooth morphogenesis. Connect Tissue Res (2005) 1.01
A neonate with umbilical arteriovenous malformation showing hemorrhagic shock from massive umbilical hemorrhage. Am J Perinatol (2009) 1.00
Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation. Matrix Biol (2012) 1.00
Bone formation with the combination of simvastatin and calcium sulfate in critical-sized rat calvarial defect. J Pharmacol Sci (2007) 0.99
Monolithic silica columns for high-efficiency chromatographic separations. J Chromatogr A (2002) 0.99
Growth arrest specific gene 1 acts as a region-specific mediator of the Fgf10/Fgf8 regulatory loop in the limb. Development (2002) 0.98
Clinical significance of BIM deletion polymorphism in non-small-cell lung cancer with epidermal growth factor receptor mutation. J Thorac Oncol (2014) 0.98
Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med (2003) 0.98
Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases. Int J Surg Pathol (2008) 0.98
Molecular genetics and epidemiology of epithelial ovarian cancer (Review). Oncol Rep (2011) 0.97
The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma. Int J Gynecol Pathol (2012) 0.97
Preventive effect of fermented brown rice and rice bran against colon carcinogenesis in male F344 rats. Oncol Rep (2002) 0.96
Nidogen-2: a new serum biomarker for ovarian cancer. Clin Biochem (2009) 0.96
Atherosclerosis in perlecan heterozygous mice. J Lipid Res (2004) 0.96
Monolithic silica columns with various skeleton sizes and through-pore sizes for capillary liquid chromatography. J Chromatogr A (2002) 0.96
Role of perlecan in skeletal development and diseases. Glycoconj J (2003) 0.96
The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells. Blood (2014) 0.96
Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas. Hum Pathol (2011) 0.96
Identification and characterization of the Na+/H+ antiporter Nhas3 from the thylakoid membrane of Synechocystis sp. PCC 6803. J Biol Chem (2009) 0.95
Immunomagnetic flow cytometric detection of staphylococcal enterotoxin B in raw and dry milk. J Food Prot (2003) 0.94